Sponsor

Gesellschaft für Therapieforschung mbH

Clinical research sponsor

Published trials7

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

7 shown

TriMaximize: A Multicentre, Prospective, Non-interventional Trial in Asthma PatientsNCT06567977 · collaborator · 2024-08-01

UNKNOWN

Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world SettingNCT06100042 · collaborator · 2024-04-24

COMPLETED

A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related OutcomesNCT05728749 · collaborator · 2023-03-03

UNKNOWN

A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comesNCT04902573 · collaborator · 2021-06-17

COMPLETED

A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After MitoxantroneNCT01142466 · collaborator · 2005-12-01

COMPLETED

An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) PatientsNCT01142453 · collaborator · 2005-05-01

COMPLETED

An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple SclerosisNCT01142557 · collaborator · 2004-06-01

COMPLETED

Sponsor roles

collaborator7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.